- Scope of the procurement
- Lot 1. Thrombotic Thrombocytopenic Purpura (TTP) – London and the South East (Kent, Surrey, East & West Sussex)
- Lot 2. Thrombotic Thrombocytopenic Purpura (TTP) - South East (Thames Valley, Hampshire and the Isle of Wight)
- Lot 3. Thrombotic Thrombocytopenic Purpura (TTP) - West Midlands
- Lot 4. Thrombotic Thrombocytopenic Purpura (TTP) - East Midlands
- Lot 5. Thrombotic Thrombocytopenic Purpura (TTP) - East of England
- Lot 6. Thrombotic Thrombocytopenic Purpura (TTP) - North East
- Lot 7. Thrombotic Thrombocytopenic Purpura (TTP) - Yorkshire and the Humber
- Lot 8. Thrombotic Thrombocytopenic Purpura (TTP) - South West
Section one: Contracting authority
one.1) Name and addresses
NHS England - Specialised Commissioning)
80 London Road
London
SE1 6LH
Country
United Kingdom
NUTS code
UK - United Kingdom
Internet address(es)
Main address
https://www.england.nhs.uk/commissioning/spec-services/
Buyer's address
https://www.ardengemcsu.nhs.uk/
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://uk.eu-supply.com/login.asp?B=AGCSU&target=
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://uk.eu-supply.com/login.asp?B=AGCSU&target=
Tenders or requests to participate must be submitted to the above-mentioned address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
NHS England Spec. Commissioning - Thrombotic Thrombocytopenic Purpura (TTP) all ages (up to 8 Lots)
Reference number
NHSSC-TPP-2021- NHS England
two.1.2) Main CPV code
- 85100000 - Health services
two.1.3) Type of contract
Services
two.1.4) Short description
Thrombotic Thrombocytopenic Purpura (TTP) is a serious blood disorder that results in blood clots forming in small blood vessels throughout the body. It affects the kidneys, heart and brain. If a patient is treated outside a specialist centre, mortality is 50%; in a specialist centre, it is 20%. There is also an appreciable acute morbidity, particularly in neurological disorders.
The Condition can be difficult to diagnose because initial presentation can be non-specific and this is a very rare disease. Rapid treatment is essential for optimal outcomes and includes plasma exchange and a range of drugs. This disease primarily affects Adults. Children are treated in paediatric haematology centres and are outside the scope of this process.
two.1.5) Estimated total value
Value excluding VAT: £54,943,200
two.1.6) Information about lots
This contract is divided into lots: Yes
Tenders may be submitted for all lots
Maximum number of lots that may be awarded to one tenderer: 1
two.2) Description
two.2.1) Title
Thrombotic Thrombocytopenic Purpura (TTP) – London and the South East (Kent, Surrey, East & West Sussex)
Lot No
1
two.2.2) Additional CPV code(s)
- 85100000 - Health services
- 85000000 - Health and social work services
two.2.3) Place of performance
NUTS codes
- UKJ4 - Kent
- UKJ2 - Surrey, East and West Sussex
- UKI - London
Main site or place of performance
London and the South East (Kent, Surrey, East & West Sussex)
two.2.4) Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting interested Providers to bid for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
There are patient flows to London from all over the South East. Commissioners have considered establishing one specialist provider for all of London and the South East and this is the default commissioner position.
Commissioners will consider bids for the South East (Thames Valley and Hampshire and Isle of Wight areas - (Lot 2)), to facilitate patient choice and to reduce the requirement to travel for providers who meet the criteria in the service specification, in the technical questionnaire and who are willing to work within a Clinical Partnership with the successful bidder for the London and South East Lot (Lot 1).
The contracting term for these services will be for a period of up to 4 years.
two.2.5) Award criteria
Quality criterion - Name: Section K : Skills and competences / Weighting: 20
Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42
Quality criterion - Name: Section M: Mobilisation / Weighting: 10
Quality criterion - Name: Section N: Education and service continuity / Weighting: 6
Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7
Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10
Quality criterion - Name: : Section Q: Networks and leadership / Weighting: 5
Price - Weighting: 0
two.2.6) Estimated value
Value excluding VAT: £20,589,200
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Please note that Lots may have changed from previous publications.
two.2) Description
two.2.1) Title
Thrombotic Thrombocytopenic Purpura (TTP) - South East (Thames Valley, Hampshire and the Isle of Wight)
Lot No
2
two.2.2) Additional CPV code(s)
- 85000000 - Health and social work services
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKJ - South East (England)
Main site or place of performance
South East (Thames Valley, Hampshire and the Isle of Wight)
two.2.4) Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years.
two.2.5) Award criteria
Quality criterion - Name: Section K : Skills and competences / Weighting: 20
Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42
Quality criterion - Name: Section M: Mobilisation / Weighting: 10
Quality criterion - Name: Section N: Education and service continuity / Weighting: 6
Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7
Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10
Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5
Price - Weighting: 0
two.2.6) Estimated value
Value excluding VAT: £4,173,800
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Please note that Lots may have changed from previous publications.
two.2) Description
two.2.1) Title
Thrombotic Thrombocytopenic Purpura (TTP) - West Midlands
Lot No
3
two.2.2) Additional CPV code(s)
- 85000000 - Health and social work services
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKG - West Midlands (England)
Main site or place of performance
West Midlands
two.2.4) Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years
two.2.5) Award criteria
Quality criterion - Name: Section K : Skills and competences / Weighting: 20
Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42
Quality criterion - Name: Section M: Mobilisation / Weighting: 10
Quality criterion - Name: Section N: Education and service continuity / Weighting: 6
Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7
Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10
Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5
Price - Weighting: 0
two.2.6) Estimated value
Value excluding VAT: £7,633,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Please note that Lots may have changed from previous publications.
two.2) Description
two.2.1) Title
Thrombotic Thrombocytopenic Purpura (TTP) - East Midlands
Lot No
4
two.2.2) Additional CPV code(s)
- 85000000 - Health and social work services
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKF - East Midlands (England)
Main site or place of performance
East Midlands
two.2.4) Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres centre in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years.
two.2.5) Award criteria
Quality criterion - Name: Section K : Skills and competences / Weighting: 20
Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42
Quality criterion - Name: : Section M: Mobilisation / Weighting: 10
Quality criterion - Name: Section N: Education and service continuity / Weighting: 6
Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7
Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10
Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5
Price - Weighting: 0
two.2.6) Estimated value
Value excluding VAT: £4,041,100
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Please note that Lots may have changed from previous publications.
two.2) Description
two.2.1) Title
Thrombotic Thrombocytopenic Purpura (TTP) - East of England
Lot No
5
two.2.2) Additional CPV code(s)
- 85000000 - Health and social work services
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKH - East of England
Main site or place of performance
East of England
two.2.4) Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years.
two.2.5) Award criteria
Quality criterion - Name: Section K : Skills and competences / Weighting: 20
Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42
Quality criterion - Name: Section M: Mobilisation / Weighting: 10
Quality criterion - Name: Section N: Education and service continuity / Weighting: 6
Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7
Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10
Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5
Price - Weighting: 0
two.2.6) Estimated value
Value excluding VAT: £4,017,500
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Please note that Lots may have changed from previous publications.
two.2) Description
two.2.1) Title
Thrombotic Thrombocytopenic Purpura (TTP) - North East
Lot No
6
two.2.2) Additional CPV code(s)
- 85000000 - Health and social work services
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKC - North East (England)
Main site or place of performance
North East
two.2.4) Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years.
two.2.5) Award criteria
Quality criterion - Name: Section K : Skills and competences / Weighting: 20
Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42
Quality criterion - Name: Section M: Mobilisation / Weighting: 10
Quality criterion - Name: Section N: Education and service continuity / Weighting: 6
Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7
Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10
Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5
Price - Weighting: 0
two.2.6) Estimated value
Value excluding VAT: £40,002,800
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Please note that Lots may have changed from previous publications.
two.2) Description
two.2.1) Title
Thrombotic Thrombocytopenic Purpura (TTP) - Yorkshire and the Humber
Lot No
7
two.2.2) Additional CPV code(s)
- 85000000 - Health and social work services
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKE - Yorkshire and the Humber
Main site or place of performance
Yorkshire and the Humber
two.2.4) Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years
two.2.5) Award criteria
Quality criterion - Name: Section K : Skills and competences / Weighting: 20
Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42
Quality criterion - Name: Section M: Mobilisation / Weighting: 10
Quality criterion - Name: Section N: Education and service continuity / Weighting: 6
Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7
Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10
Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5
Price - Weighting: 0
two.2.6) Estimated value
Value excluding VAT: £4,851,400
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Please note that Lots may have changed from previous publications.
two.2) Description
two.2.1) Title
Thrombotic Thrombocytopenic Purpura (TTP) - South West
Lot No
8
two.2.2) Additional CPV code(s)
- 85000000 - Health and social work services
- 85100000 - Health services
two.2.3) Place of performance
NUTS codes
- UKK - South West (England)
two.2.4) Description of the procurement
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.
There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.
NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.
The contracting term for these services will be for a period of up to 4 years
two.2.5) Award criteria
Quality criterion - Name: Section K : Skills and competences / Weighting: 20
Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42
Quality criterion - Name: Section M: Mobilisation / Weighting: 10
Quality criterion - Name: Section N: Education and service continuity / Weighting: 6
Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7
Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10
Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5
Price - Weighting: 0
two.2.6) Estimated value
Value excluding VAT: £5,634,400
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
48
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Please note that Lots may have changed from previous publications.
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.3) Technical and professional ability
List and brief description of selection criteria
All technical capacity and its evaluation criteria are specified within the tender documentation.
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2021/S 000-006895
four.2.2) Time limit for receipt of tenders or requests to participate
Date
25 June 2021
Local time
5:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.7) Conditions for opening of tenders
Date
25 June 2021
Local time
5:00pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.3) Additional information
In response to a recommendation from the Prescribed Specialised Services Advisory Group in 2014, NHS England developed a service model that aimed to balance the high levels of multi-disciplinary expertise required to treat patients with TTP with the requirement for patients to be treated rapidly to have optimal outcomes. NHS England undertook a public consultation on the draft service specification, which closed in October 2018. The consultation documents are still available on the NHS England website at this link:
Consultation on service specifications for thrombotic thrombocytopenic purpura (TTP) for all ages - NHS England - Citizen Space.
The model of delivery is to offer in-patient care within a specialist TTP centre, Patients with TTP require lifelong monitoring and follow up to manage relapse. Shared care is possible, based on the preference of the patient. Specialist TTP centres are required to undertake a clinical leadership, proactive education and outreach service to hospitals within their region to improve the identification of patients with TTP and the timely referral of patients to the specialist TTP centres. Specialist TTP centres are required to establish robust clinical partnerships with paediatric haematology centres to provide support in relation to the treatment of children and to agree a transition policy.
There are patient flows to London from all over the South East. Commissioners have considered establishing one provider for all of London and the South East and this is the default Commissioner position. Commissioners will consider bids for the South East (Thames Valley and Hampshire and Isle of Wight areas, (Lot 2)) to facilitate patient choice and to reduce the requirement to travel for providers who meet the criteria in the service specification, in the technical questionnaire and who are willing to work within a Clinical Partnership with the successful bidder for the London and South East Lot (Lot 1).
This will support effective care and improve local patient access to the service whilst ensuring availability of clinical expertise as appropriate.
To register your interest in these services please follow this link https://uk.eu-supply.com/ctm/supplier/publictenders?B=UK and either login or register on EU Supply and search from ID number 43998. All Bidders are asked to complete the general Qualification and Technical questions and the Lot specific Qualification and Technical Questions for the Lots they are applying for. Bidders may apply for more than one Lot, but will only be awarded a maximum of one Lot. Please refer to the Process Selection Process Overview documents for further details.
six.4) Procedures for review
six.4.1) Review body
Arden & GEM Commissioning Support Unit
Derby
DE1 3QT
Country
United Kingdom
six.4.2) Body responsible for mediation procedures
Arden & GEM Commissioning Support Unit
Derby
DE1 3QT
Country
United Kingdom
six.4.4) Service from which information about the review procedure may be obtained
Arden & GEM Commissioning Support Unit
Derby
DE1 3QT
Country
United Kingdom